PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Memorial Sloan Kettering Cancer Center, New York, New York, USA. Electronic address: Canciom@mskcc.org.\', \'Department of Medicine, A.O.U.I Policlinico G.B Rossi and University of Verona, Verona, Italy.\', \'Laboratory of Pulmonary Investigation, Carlos Chagas Filho Institute of Biophysics, Federal university of Rio de Janeiro, Rio de Janeiro, Brazil.\', \'Center for Cellular Immunotherapies and Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.\', \'Center for Cancer and Immunology Research, Center for Cancer and Blood Disorders, Children\'s National Hospital and the George Washington University Cancer Center, George Washington University, Washington, DC, USA.\', \'University of Vermont Medical Center, Burlington, Vermont, USA.\', \'Memorial Sloan Kettering Cancer Center, New York, New York, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1465-3249(20)30657-510.1016/j.jcyt.2020.04.100
?:doi
?:hasPublicationType
?:journal
  • Cytotherapy
is ?:pmid of
?:pmid
?:pmid
  • 32565132
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.144
?:rankingScore_hIndex
  • 72
is ?:relation_isRelatedTo_publication of
?:title
  • Emerging trends in COVID-19 treatment: learning from inflammatory conditions associated with cellular therapies.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all